Items per page
Sort by

Send to:

Choose Destination

Results: 13

References for PMC Articles for PubMed (Select 22306768)


All circulating EpCAM+CK+CD45- objects predict overall survival in castration-resistant prostate cancer.

Coumans FA, Doggen CJ, Attard G, de Bono JS, Terstappen LW.

Ann Oncol. 2010 Sep;21(9):1851-7. doi: 10.1093/annonc/mdq030. Epub 2010 Feb 10.


Circulating tumour cells in clinical practice: Methods of detection and possible characterization.

Alunni-Fabbroni M, Sandri MT.

Methods. 2010 Apr;50(4):289-97. doi: 10.1016/j.ymeth.2010.01.027. Epub 2010 Jan 29. Review.


Cytomorphology of circulating colorectal tumor cells:a small case series.

Marrinucci D, Bethel K, Lazar D, Fisher J, Huynh E, Clark P, Bruce R, Nieva J, Kuhn P.

J Oncol. 2010;2010:861341. doi: 10.1155/2010/861341. Epub 2010 Jan 6.


Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer.

Miller MC, Doyle GV, Terstappen LW.

J Oncol. 2010;2010:617421. doi: 10.1155/2010/617421. Epub 2009 Dec 9.


Circulating tumor cells from well-differentiated lung adenocarcinoma retain cytomorphologic features of primary tumor type.

Marrinucci D, Bethel K, Luttgen M, Bruce RH, Nieva J, Kuhn P.

Arch Pathol Lab Med. 2009 Sep;133(9):1468-71. doi: 10.1043/1543-2165-133.9.1468.


Cancer micrometastases.

Pantel K, Alix-Panabières C, Riethdorf S.

Nat Rev Clin Oncol. 2009 Jun;6(6):339-51. doi: 10.1038/nrclinonc.2009.44. Review.


The CTC-chip: an exciting new tool to detect circulating tumor cells in lung cancer patients.

Sequist LV, Nagrath S, Toner M, Haber DA, Lynch TJ.

J Thorac Oncol. 2009 Mar;4(3):281-3. doi: 10.1097/JTO.0b013e3181989565.


Detection of mutations in EGFR in circulating lung-cancer cells.

Maheswaran S, Sequist LV, Nagrath S, Ulkus L, Brannigan B, Collura CV, Inserra E, Diederichs S, Iafrate AJ, Bell DW, Digumarthy S, Muzikansky A, Irimia D, Settleman J, Tompkins RG, Lynch TJ, Toner M, Haber DA.

N Engl J Med. 2008 Jul 24;359(4):366-77. doi: 10.1056/NEJMoa0800668. Epub 2008 Jul 2.


Isolation of rare circulating tumour cells in cancer patients by microchip technology.

Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, Ulkus L, Smith MR, Kwak EL, Digumarthy S, Muzikansky A, Ryan P, Balis UJ, Tompkins RG, Haber DA, Toner M.

Nature. 2007 Dec 20;450(7173):1235-9.


Case study of the morphologic variation of circulating tumor cells.

Marrinucci D, Bethel K, Bruce RH, Curry DN, Hsieh B, Humphrey M, Krivacic RT, Kroener J, Kroener L, Ladanyi A, Lazarus NH, Nieva J, Kuhn P.

Hum Pathol. 2007 Mar;38(3):514-9. Epub 2006 Dec 22.


High speed detection of circulating tumor cells.

Hsieh HB, Marrinucci D, Bethel K, Curry DN, Humphrey M, Krivacic RT, Kroener J, Kroener L, Ladanyi A, Lazarus N, Kuhn P, Bruce RH, Nieva J.

Biosens Bioelectron. 2006 Apr 15;21(10):1893-9. Epub 2006 Feb 7.


Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases.

Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, Tibbe AG, Uhr JW, Terstappen LW.

Clin Cancer Res. 2004 Oct 15;10(20):6897-904.


Circulating tumor cells, disease progression, and survival in metastatic breast cancer.

Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW, Hayes DF.

N Engl J Med. 2004 Aug 19;351(8):781-91.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk